Related Experiment Video
Updated: May 24, 2026
05:44
Rodent Inferior Vena Cava Venoplasty Balloon Model
Published on: May 24, 2024
Progestin-only contraception and venous thromboembolism.
M A Blanco-Molina1, M Lozano, A Cano
1Medicine Department, Hospital Reina Sofía, Córdoba, Spain.
Thrombosis Research
|March 20, 2012
Summary
Combined oral contraceptives (COCs) are popular but carry a risk of venous thromboembolism (VTE). This review examines progestin effects on hemostasis, VTE risk, and eligibility for hormonal contraception in women with VTE or thrombophilia.
Area of Science:
- Reproductive Health
- Pharmacology
- Hematology
Background:
- Combined oral contraceptives (COCs) are widely used globally.
- Modifications to COCs focus on improving safety and tolerability while maintaining efficacy.
- Progestin component alterations are common, with ethinyl estradiol as the standard estrogen.
Purpose of the Study:
- To review hemostatic changes induced by progestin-only contraceptives.
- To assess venous thromboembolism (VTE) risk associated with progestin-only contraceptives.
- To examine eligibility for hormonal contraception in women with prior VTE or thrombophilia.
Main Methods:
- Literature review of studies on progestin contraceptives and hemostasis.
- Analysis of VTE risk data in users of progestin-only contraceptives.
- Evaluation of interactions with anticoagulant therapy and thrombophilia risk factors.
Main Results:
- Progestins influence hemostasis, impacting VTE risk.
- Specific progestins may have varying effects on VTE risk.
- Thrombophilia and anticoagulant interactions require careful consideration.
Conclusions:
- Understanding progestin-induced hemostatic changes is crucial for VTE risk assessment.
- Individualized assessment is necessary for prescribing hormonal contraception to women with VTE or thrombophilia history.
- Further research is needed to clarify the VTE risk associated with different progestins.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:22Birth Control Methods
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although vasectomy...
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...